GLENDALE, CA – March 29, 2022 – emTRUTH®, whose mission is to help healthcare companies unlock the full value of their data, announced today that it has received intellectual property protection for its technology in the…
San Francisco, CA – On March 25rd, THE OBSIDIAN – a consortium of Black tech, media and academic professionals – announced the launch of their second annual OBSIDIAN Awards. Dubbed “The Rock,” the crowd-sourced award is…
Washington, DC – March 25, 2022 – USA Guided Tours COO, Claudio Herrera Krell, announced that it’s now booking its unique sightseeing tours for New York City and Washington, DC. The award-winning tour service offers day and…
DUBAI, UAE – 25 MARCH, 2022 – Pionauts, one of the most unique and groundbreaking NFT art collections, is set to launch on 28 April 2022, announced Johan Van Asperen Vervenne, the founder and visionary behind…
San Francisco – 24th March, 2022 – Starship Optimus is the new interplanetary cryptocurrency in the cosmos promising to fund a fleet of ships and robots on their journey to colonize Mars. The developers visualize a…
Orlando, FL – March 24th, 2022 – Commercial Fitness Products, Inc., one of the industry’s oldest and largest commercial equipment suppliers led by Richard Wasserlauf, President, has expanded into a new Orlando location to better serve…
Jamile African Products discusses the history of African clothing and fashion trends from ancient times to modern era! African clothing, fashion and fabrics have long been misunderstood by the rest of the world. Africa is…
The BookFest returns for a 5th biannual online bookish adventure April 2nd and 3rd with an array of authors, literary experts, and speakers. The wonders of the Universe are a theme during a conversation about…
Suzie Newell’s “Path 365” Is a Daily Life Guide that Helps Foster a Healthy Mindset. Clinton, Ohio – In today’s fast-paced and unpredictable world, everybody needs effective coping strategies to deal with anxiety and change. Based…
MOUNTAIN VIEW, CA – March 23, 2022 – Adge Pharmaceuticals Inc. has secured a global license to RO269228, a clinical stage oral small molecule originally developed by Roche for osteoporosis. Adge is now evaluating the molecule…